Written Question·Department of Health and Social Care·UIN 53047
Medical Treatments and Tofersen
Tabled: 19 May 2025
Answered: 27 May 2025
Question
Jim Shannon
Democratic Unionist Party — Strangford
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of Early Access Programmes on equity of access to (a) tofersen and (b) other innovative treatments.
Answer
Karin SmythEarly access schemes for unlicenced medicines, where approval may be obtained in other markets, including where a licence exists but a National Institute for Health and Care Excellence decision is not available, are managed by companies to benefit patient...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 53047) →